Aquipta banner

DESIGNED TO
PREVENT MIGRAINE^1

AQUIPTA is a simple once-daily tablet that works fast† to prevent migraine.1,2

^In 3-month clinical studies, AQUIPTA significantly reduced monthly migraine days.1
†In a clinical study, 87.7% of patients who received AQUIPTA 60 mg did not have a migraine on day 1 after first dose compared to 74.8% on placebo.2

Aquipta Pack

AQUIPTA (atogepant) is a prescription medicine used to prevent migraine in patients who have at least 4 migraine days per month.3

AQUIPTA is a prescription medicine that is not funded. It is available for private purchase, which means you will need to pay for this medicine.
Please refer to the How to Access page for more information.

References: 1. AQUIPTA® (atogepant) Data Sheet. 2. Schwedt TJ, et al. Cephalalgia. 2022;42(1):3-11. 3. AQUIPTA® (atogepant) Consumer Medicine Information.

NZ-AQP-240017. TAPS BG4309. ABB2630. Date prepared September 2024.